PROCESS FOR PURIFICATION OF IMMUNOGLOBULINS USING A PSEUDOBIOAFFINITY ADSORBENT

• US 20100113746A1
• Filed: 04/23/2008
• Published: 05/06/2010
• Est. Priority Date: 04/23/2007
• Status: Abandoned Application

• Current Assignee: Institute Of Chemical Technology
• Original Assignee: Arvind Mallinath Lali
• Inventors: Lali, Arvind Mallinath, Naik, Amith Dattatray, Kale, Sandeep Bhaskar, Raina, Monika
• Application Number:
  US12/597,136
• Publication Number:
  US 20100113746A1
• Time in Patent Office: Days
• US Class Current: 530/387.100
• CPC Class Codes: C07K 16/065 Purification, fragmentation
• CPC Class Codes: Y10T 428/249991 Synthetic resin or natural rubbers
• CPC Class Codes: Y10T 428/249992 Linear or thermoplastic

Abstract

The present invention relates to the development of pseudobioaffinity adsorbent and process for purification of immunoglobulin G from immunoglobulin containing solutions such as but not limited to plasma, serum, cell culture supernatant, ascites fluids. The adsorbent consists of a solid support and ligand. The ligand may be attached to the matrix or be part of matrix. The ligand is selected from a group of hydrophobic amino acids such as alanine, valine, leucine, isoleucine, proline, phenylalanine, tryptophan and tyrosine and the support material being preferably a synthetic hydrophilic polymer of methacrylate or acrylate species, or any of its derivatives. The adsorbent is cheap and stable to harsh conditions such as 1.0 M NaOH used during regeneration of adsorbents. Moreover there is no problem of toxic leachables typically associated with biological ligands. The nature of the adsorbent also allows high flow rate operations at relatively low pressures. The process includes adjusting the pH and conductivity of the feed solution and the use of ionic salts and additives such as polyols or alcohols for eluting the bound IgG.

Claims

1-13. -13. (canceled)

14. A process for immunoglobulin purification/separation using pseudobioaffinity adsorbent comprising:

a. providing a rigid, porous pseudobioaffinity adsorbent comprising an amalgamation of a hydrophilic polymer base/support and attached/immobilized affinity ligand/s including (i) aliphatic and/or aromatic propanoic acid derivative/s and/or (ii) aliphatic or aromatic hydrophobic amino acids, or (iii) any suitable combinations thereof with average ligand density between 0.1 to 0.2 mol/lit (i.e. 100 to 200 μ

mol/ml) with or without a spacer arm and leading to ionic, hydrophobic and/or mixed mode interaction/s between the said pseudobioaffinity adsorbent and an immunoglobulin;

b. contacting the said adsorbent with an immunoglobulin containing solution directly, or after adjusting the pH and conductivity of the immunoglobulin containing solution to adsorb the immunoglobulins on the said adsorbent with high specificity and high selectivity with a high immunoglobulin adsorption capacity between 25 to 120 mg immunoglobulins/ml (i.e. 33 to 160 g/kg) of adsorbent;

c. optionally washing the said adsorbent with a washing solution;

d. contacting the said adsorbent with desorbing solution in order to elute the bound immunoglobulin and fragments thereof with recovery and purity of 80% to 100% and 90 to 100% respectively; and

e. optionally, regenerating and equilibrating the said adsorbent for reuse.

15. A pseudobioaffinity adsorbent comprising an amalgamation of a rigid porous hydrophilic polymer base/support material of methacrylate or acrylate species, or any of its derivatives and attached/immobilized affinity ligand/s which is selected from a group consisting of (i) aliphatic and/or aromatic propanoic acid derivative/s and/or (ii) aliphatic or aromatic hydrophobic amino acids, and (iii) any suitable combinations thereof with average ligand density between 0.1 to 0.2 mol/lit (i.e. 100 to 200 μ

mol/ml) with or without a spacer arm;

said adsorbent having high specificity and high selectivity with a high immunoglobulin adsorption capacity between 25 to 120 mg immunoglobulins/ml (i.e. 33 to 160 g/kg) of adsorbent.

16. A pseudobioaffinity adsorbent of claim 15, wherein the rigid porous hydrophilic polymer support material comprises synthetic hydrophilic polymer of acrylate or methacrylate species, or compounds, or any of their derivatives selected from a group consisting of polymethacrylate, polyacrylate, polymethylmethacrylate, polyhydroxyethyl-methacrylate or polyglycidyl methacrylate, or their combinations within themselves, or with other natural or synthetic copolymers.

17. A pseudobioaffinity adsorbent of claim 15, wherein the ligands support material is selected from the group consisting of a methacrylate polymer, and a co-polymer of methacrylate and acrylic acid.

18. A pseudobioaffinity adsorbent of claim 15, wherein ligand is selected from the group consisting of propanoic acid derivatives, natural amino acids, synthetic amino acids, aliphatic amino acids, aromatic hydrophobic amino acids in D form or L form, alanine, valine, leucine, isoleucine, proline, phenylalanine, tryptophan and tyrosine coupled to the rigid support.

19. A pseudobioaffinity adsorbent of claim 15, wherein ligand is selected from the group consisting of a derivative of propanoic acid, an aromatic hydrophobic amino acid and tryptophan, coupled to the rigid and porous support.

20. A pseudobioaffinity adsorbent of claim 15, wherein the support material is in the form of spherical beads, irregular particles, membrane sheets, molded surfaces or sticks.

21. A pseudobioaffinity adsorbent of claim 15, wherein the support material is in the form of spherical beads of size in the range of 5 μ

m to 2000 μ

m.

22. A pseudobioaffinity adsorbent of claim 15, wherein the support material is in the form of spherical beads of size in the range of 20 μ

m to 1000 μ

m.

23. A pseudobioaffinity adsorbent of claim 15, wherein the ligand is attached to the support matrix, with or without a spacer arm, or it is attached to the monomeric and oligomeric constituents of the matrix prior to polymerization to form an adsorbent matrix.

24. A process of separation/purification of immunoglobulin/s, said process comprising:

a) packing pre-equilibrated pseudobioaffinity adsorbent in a chromatographic column;

b) contacting immunoglobulin containing solutions with said pre-equilibrated pseudobioaffinity adsorbent for selective binding of immunoglobulin to the pseudobioaffinity adsorbent under the conditions of pH in the range of 2.5 to 9.0, and salt content in terms of conductivity in the range 0.5 mS/cm to 50 mS/cm, where contaminating proteins remain in the unadsorbed fraction;

c) washing the pseudobioaffinity adsorbent with a buffer, having the same or near properties of pH and salt strength as in step (b) above, to remove unadsorbed, or weakly adsorbed, compounds;

d) eluting the bound immunoglobulin in 80% to 100% recovery and 90% to 100% purity by washing the pseudobioaffinity adsorbent with desorbing buffer having pH in the range of 2.5 to 9.0, and containing ionic salts so that conductivity is in the range of 20 mS/cm to 140 mS/cm and also containing additives selected from a group consisting of alcohol, polyols, ethanol, sugars, polyethylene glycol, ethylene glycol and glycerol; and

e) regenerating and re-equilibrating the pseudobioaffinity adsorbent for reuse.

25. The process according to claim 24, wherein the pseudobioaffinity adsorbent is contacted with the immunoglobulin containing solution, washing solution, eluting solution, regenerating and equilibrating solution in a mode selected from the group consisting of batch mode, stirred batch mode, packed bed mode, expanded bed, fluidized bed mode and moving bed.

26. The process according to claim 24, wherein the buffer is selected from the group consisting of acetate, phosphate, MES, carbonate, glycine-HCl, Tris-HCl and HEPES.

27. The process according to claim 24, wherein the additives added to the buffer are selected from the group consisting of ethanol, ethylene glycol, glycerol, polyethylene glycol and sugars.